PGAM
Princeton Global Asset Management’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-83
| Closed | -$9K | – | 570 |
|
|
2022
Q3 | $9K | Hold |
83
| – | – | ﹤0.01% | 399 |
|
|
2022
Q2 | $8K | Hold |
83
| – | – | ﹤0.01% | 426 |
|
|
2022
Q1 | $8K | Hold |
83
| – | – | ﹤0.01% | 471 |
|
|
2021
Q4 | $7K | Hold |
83
| – | – | ﹤0.01% | 436 |
|
|
2021
Q3 | $8K | Hold |
83
| – | – | ﹤0.01% | 422 |
|
|
2021
Q2 | $8K | Hold |
83
| – | – | ﹤0.01% | 431 |
|
|
2021
Q1 | $8K | Hold |
83
| – | – | ﹤0.01% | 401 |
|
|
2020
Q4 | $8K | Hold |
83
| – | – | ﹤0.01% | 403 |
|
|
2020
Q3 | $8K | Hold |
83
| – | – | ﹤0.01% | 359 |
|
|
2020
Q2 | $10K | Hold |
83
| – | – | ﹤0.01% | 418 |
|
|
2020
Q1 | $7K | Hold |
83
| – | – | ﹤0.01% | 411 |
|
|
2019
Q4 | $9 | Hold |
83
| – | – | ﹤0.01% | 442 |
|
|
2019
Q3 | $8K | Sell |
83
-14
| -14% | -$1.35K | ﹤0.01% | 303 |
|
|
2019
Q2 | $8K | Buy |
+97
| New | +$8K | ﹤0.01% | 337 |
|